Poland to Buy 96 Boeing AH-64E Apache Helicopters From U.S.
Magellan Aerospace Signs Long-term Contract With Pratt & Whitney for Complex Castings
Wells Fargo Initiates Coverage On Equifax With Overweight Rating, Announces Price Target of $340
Equifax Analyst Ratings
TransUnion Analyst Ratings
What's Going On With Snowflake Stock Monday?
Poland Signs $1.2B Deal With Raytheon for Patriot Missile Defense Systems
After a volatile week, Goldman Sachs reevaluates AI stocks: high-quality companies are very attractive.
Goldman Sachs pointed out that even though the market is tired of AI concept stocks, high-quality AI stocks are still attractive as these companies have strong technical foundations, market positions, or growth potential in the AI field. In addition, Nvidia's financial report, which will be released at the end of this month, may have a major impact on the entire AI market.
Shopify, Palantir And Uber Are Among Top 10 Large Cap Gainers Last Week (Aug 4-Aug 10): Are The Others In Your Portfolio?
About 73% of the S&P 500 Names Beat on EPS During the Week - Earnings Scorecard
12 Out of 17 Healthcare Companies Beat Profit Estimates This Week- Earnings Scorecard
Gilead Exits J&J Royalty Deal for Liver Drug Ahead of Potential FDA Nod
RBC Capital Maintains Sector Perform on Gilead Sciences, Raises Price Target to $72
Analysts Cite Improved Investor Sentiment For Gilead, But Warn of Limited Growth at Current Stock Levels
Wall Street Momentum Stalls After Thursday's Rally, Palantir Jumps To 3-Year Highs, Bonds Rally: What's Driving Markets Friday?
74 S&P 500 Stocks That Can Beat the Cash Yield - BofA
Smart Money Is Betting Big In ADBE Options
Gilead Sciences Analyst Ratings
S&P 500 Tries Its Best to Rebound With Best Day In A Year | Wall Street Today
Gilead Sciences in Charts: Sales From HIV, Liver Disease, and Oncology Therapies Advances in Q2